Biomarkers in chronic graft-versus-host disease - quo vadis?

Biomarkers are increasingly used for diagnosis and treatment of transplant related complications including the first biomarker-driven interventional trials of acute graft-versus-host disease (GvHD). In contrast, the development of biomarkers of chronic GvHD (cGvHD) has lagged due to a broader variet...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Bone Marrow Transplant
Prif Awduron: Wolff, D., Greinix, H., Lee, S.J., Gooley, T., Paczesny, S., Pavletic, S., Hakim, F., Malard, F., Jagasia, M., Lawitschka, A., Hansen, J.A., Pulanic, D., Holler, E., Dickinson, A., Edinger, M., Sarantopoulos, S., Schultz, K. R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2018
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6041126/
https://ncbi.nlm.nih.gov/pubmed/29367715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-018-0092-x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg